Infliximab Seen Safe, Effective for Refractory Ocular Inflammatory Disease

Reuters Health

Retrospective data indicate that infliximab is an effective therapy for a wide variety of noninfectious ocular inflammatory disease refractory to traditional immunomodulatory therapy, with a low incidence of side effects.
  • <<
  • >>

Comments